A Bioequivalence Study of Hetrombopag in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study consists of two parts. Part 1 is a pilot BE study, and Part 2 is a pivotal study to demonstrate the bioequivalence of test and reference formulation, both of which adopt a single-center, randomized, open-label, three-period crossover design.
Epistemonikos ID: 0c021d0d2efe8c251f401615d32a97d54e7c56c9
First added on: May 09, 2024